Application of energized mesenchymal stem cells in anti-tuberculosis infection of macrophages
By co-culturing mesenchymal stem cells and macrophages after empowerment, their immune regulation mechanism was studied, and the problem of unclear MSCs regulation mechanism in tuberculosis treatment was solved, and the anti-tuberculosis ability of macrophages was significantly improved, providing tuberculosis treatment with tuberculosis New theoretical and technical support.
Patent Information
- Application Number
- CN202411494183.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-24
- Publication Date
- 2024-12-06
Smart Images

Figure CN119074771A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedicine technology, and specifically relates to the application of empowered mesenchymal stem cells in macrophages against tuberculosis infection. Background Art
[0002] Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) and is the leading cause of death worldwide. [1] At present, the treatment of tuberculosis mainly relies on the combined use of multiple anti-tuberculosis drugs, but improper use of drugs or infection with drug-resistant strains often lead to drug resistance. [2] , developing new treatments to reduce the mortality rate of patients with drug-resistant tuberculosis has become a technical bottleneck in the field of tuberculosis prevention and control.
[0003] Mesenchymal stem cells (MSCs) are multipotent stem cells derived from the early mesoderm. They are mainly distributed in various tissues such as bone marrow, bone, cartilage, and fat. Under certain conditions, they can differentiate into various cells such as bone, cartilage, and fat. [3] In recent years, MSCs have attracted more and more attention because scientists have found that they have low immunogenicity and can participate in immune regulation. [4] MSCs can not only regulate the proliferation and function of innate immunity such as macrophages and major adaptive immune cell groups such as T cells, B cells and natural killer (NK) cells, but also regulate the activity of dendritic cells (DCs) and can induce regulatory T cells in vivo and in vitro. [5,6] , and these immune cells play a very important role in resisting pathogens such as Mtb infection.
[0004] MSCs, as a new cell therapy, has seen new hope in the treatment of tuberculosis. Clinical trials of MSCs in the treatment of DR-TB patients have shown that it is safe and effective in improving prognosis. In 2008, Erokhin performed autologous MSCs systemic adjuvant chemotherapy on 15 MDR-TB and 12 XDR-TB patients, and found that the clinical symptoms of all patients were improved. Among them, 20 patients had a significant decrease in sputum bacterial count after 3-4 months of treatment. After 1.5-2 years, 9 patients had no recurrence in long-term follow-up. [7] In 2014, Skahin et al. reported a phase 1 randomized controlled trial (N=60) of using patients' own MSCs and standard anti-tuberculosis drugs to treat MDR-TB. After 1.5 years, it was observed that the cure rate of the experimental group was significantly higher than that of the control group (53.3% vs. 16.7%), and the safety was good, which preliminarily confirmed the feasibility of MSCs in treating tuberculosis.[8] .
[0005] Although many clinical studies based on MSCs for the treatment of tuberculosis have achieved positive results, the research on the relationship between MSCs and tuberculosis treatment is still in the exploratory stage. In the future, we still need to explore in depth and maximize the therapeutic potential of mesenchymal stem cells to better enable MSCs-mediated stem cell therapy to truly move from the laboratory to the clinic. Summary of the invention
[0006] In view of this, the purpose of the present invention is to overcome the deficiencies of the above-mentioned prior art and provide the use of empowered mesenchymal stem cells in macrophages against tuberculosis infection.
[0007] To achieve the above object, the technical solution of the present invention is as follows:
[0008] Use of empowered mesenchymal stem cells in the relief and / or adjuvant treatment and / or therapeutic drugs for tuberculosis.
[0009] Furthermore, the empowered mesenchymal stem cells are mesenchymal stem cells activated by induction of inflammatory cytokines.
[0010] Furthermore, the inflammatory cytokine is at least one of IFN-γ, TNF-α and IL-1β.
[0011] Furthermore, the drug is used to regulate the anti-Mycobacterium tuberculosis ability of macrophages.
[0012] Compared with the prior art, the present invention has the following beneficial effects:
[0013] In the present invention, the empowered MSCs are co-cultured with infected macrophages to detect the release of intracellular ROS, the expression of pro-inflammatory factors, the cell apoptosis rate, pyroptosis-related indicators, and the expression of differentially expressed genes by transcriptome sequencing and RT-qPCR; by analyzing the ability of empowered MSCs to kill Mycobacterium tuberculosis by macrophages, the immune regulatory mechanism of MSCs against tuberculosis after immune empowerment is deeply explored, which fills the gap in the regulatory mechanism of MSCs in the body's immune system against Mycobacterium tuberculosis, is of great significance for the treatment of tuberculosis, provides a theoretical basis and technical support for promoting the industrial transformation of MSCs and the application of tuberculosis treatment, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 The effect of different concentrations of cytokines on the stemness of MSCs;
[0015] Figure 2 The effects of different concentrations of cytokines on the immunoregulatory ability of MSCs;
[0016] Figure 3 To detect the inflammatory factors of macrophages by pre-treated MSCs;
[0017] Figure 4 Promote ROS release from macrophages for MSCs;
[0018] Figure 5 The ability of MSCs to promote macrophage apoptosis;
[0019] Figure 6 To show the changes of cell pyroptosis-related indicators after co-culture of pretreated MSCs with THP1 macrophages infected with H37Ra;
[0020] Figure 7 Comparison of differentially expressed genes between macrophages phagocytosing Mtb treated with MSCs pretreated with 10 ng / mL IL-1β and macrophages phagocytosing Mtb not treated with MSCs, where A is a statistical bar graph of the number of differentially expressed genes, B is a volcano graph of differentially expressed genes, C is a heat map of up-regulated differentially expressed genes, and D is a heat map of down-regulated differentially expressed genes;
[0021] Figure 8 The GO functional classification of differentially expressed genes between MSCs-treated Mtb-phagocytic macrophages pretreated with 10 ng / mL IL-1β and MSCs-treated Mtb-phagocytic macrophages not treated with MSCs, where A is the GO functional analysis of up-regulated differentially expressed genes and B is the GO functional analysis of down-regulated differentially expressed genes;
[0022] Fig. 9 KEGG analysis of differentially expressed genes between macrophages phagocytosing Mtb treated with MSCs pretreated with 10 ng / mL IL-1β and macrophages phagocytosing Mtb not treated with MSCs, where A is the KEGG analysis of up-regulated differentially expressed genes and B is the KEGG analysis of down-regulated differentially expressed genes;
[0023] Fig.10 Comparison of differentially expressed genes between macrophages phagocytosing Mtb treated with MSCs pretreated with 20 ng / mL IFN-γ and macrophages phagocytosing Mtb not treated with MSCs, where A is a statistical bar graph of the number of differentially expressed genes, B is a volcano graph of differentially expressed genes, C is a heat map of up-regulated differentially expressed genes, and D is a heat map of down-regulated differentially expressed genes;
[0024] Fig.11 The GO functional classification of differentially expressed genes between macrophages phagocytosing Mtb treated with MSCs pretreated with 20 ng / mL IFN-γ and macrophages phagocytosing Mtb not treated with MSCs, where A is the GO functional analysis of up-regulated differentially expressed genes, and B is the GO functional analysis of down-regulated differentially expressed genes;
[0025] Fig.12KEGG enrichment analysis of differentially expressed genes between macrophages phagocytosing Mtb treated with MSCs pretreated with 20 ng / mL IFN-γ and macrophages phagocytosing Mtb not treated with MSCs, where A is KEGG enrichment analysis of up-regulated differentially expressed genes, and B is KEGG enrichment analysis of down-regulated differentially expressed genes;
[0026] Fig.13 Comparison of differentially expressed genes between phagocytic Mtb macrophages pretreated with 20 ng / mL-IFN-γ and phagocytic Mtb macrophages pretreated with MSCs, where A is a statistical bar graph of the number of differentially expressed genes, B is a volcano graph of differentially expressed genes, C is a heat map of up-regulated differentially expressed genes, and D is a heat map of down-regulated differentially expressed genes;
[0027] Fig.14 The GO functional classification of differentially expressed genes between macrophages phagocytosing Mtb pretreated with 20 ng / mL-IFN-γ and macrophages phagocytosing Mtb pretreated with MSCs, where A is the GO functional analysis of up-regulated differentially expressed genes and B is the GO functional analysis of down-regulated differentially expressed genes;
[0028] Fig.15 KEGG enrichment analysis of differentially expressed genes between macrophages phagocytosing Mtb pretreated with 20 ng / mL-IFN-γ and macrophages phagocytosing Mtb pretreated with MSCs, where A is KEGG enrichment analysis of up-regulated differentially expressed genes, and B is KEGG enrichment analysis of down-regulated differentially expressed genes;
[0029] Fig.16 The VEN graphs of differentially regulated genes and PPI networks of differentially regulated proteins of 20ng / mL-IFN-γ-MSCs / MSCs, MSCs / NC and 20ng / mL-IFN-γ-MSCs / NC, where A is the VEN graph of up-regulated differentially regulated genes, B is the VEN graph of down-regulated differentially regulated genes, C is the PPI network of up-regulated differentially regulated proteins, and D is the PPI network of down-regulated differentially regulated proteins;
[0030] Fig.17 Differential gene analysis of immune-empowered MSCs regulating the anti-Mtb ability of macrophage THP1. DETAILED DESCRIPTION
[0031] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein.
[0032] GraphPad Prism 8.0 was used for statistical analysis in the following examples, and Student's T test was used. *P<0.05, **P<0.01 indicated statistically significant differences.
[0033] Example 1 Effects of immune empowerment on MSCs stemness and immune regulation
[0034] In order to explore the maintenance of stemness after pretreatment of MSCs, the present invention detected the expression of OCT-4, NANOG, REX1 and SOX2, which are stemness maintenance indicators of MSCs treated with IFN-γ, TNF-α and IL-1β, by RT-qPCR; in order to explore the immunoregulatory ability of MSCs after cytokine pretreatment, the present invention detected the expression of inflammatory indicators IL-1β, IL-6 and TNF-α of MSCs treated with IFN-γ, TNF-α and IL-1β by RT-qPCR.
[0035] The experimental process is as follows: First, follow the Trizol total RNA extraction kit of Tiangen Company: ① discard the original MSCs culture medium and add pre-cooled PBS to wash the cells; ② discard PBS, add 1mL Trizol and blow evenly, and let it stand on ice for 5 minutes; ③ transfer the liquid to a 1.5mL EP tube; ④ add 200μL chloroform, mix evenly, and let it stand on ice for 5 minutes; ⑤ 4℃, 13000rpm, centrifuge for 10 minutes; ⑥ carefully take the supernatant to a new EP tube, add an equal volume of isopropanol, mix well, -20℃, 30 minutes; ⑦ 4℃, 13000rpm, centrifuge for 10 minutes; ⑧ discard the supernatant, RNA white precipitate can be seen, wash twice with 75% ethanol 500μL, shake well; ⑨ 4℃, 8000rpm, centrifuge for 7 minutes; ⑩ discard the supernatant and blow dry on the clean bench until no white precipitate can be seen; Add 15-20 μL of RNase-free ddH2O to resuspend the RNA precipitate and mix well; After measuring the RNA concentration, reverse transcription was performed and the rest was stored at -80°C; then mRNA was reverse transcribed into cDNA according to Yisheng Company; finally, RT-qPCR was used to detect the expression of IFN-γ, TNF-α and IL-1β-treated MSCs stemness maintenance indicators - OCT-4, NANOG, REX1 and SOX2, and the expression of inflammatory indicators - IL-1β, IL-6 and TNF-α by using the Novozyme kit. The primer sequences for the detection are:
[0036] The β-actin forward primer sequence was: 5′-CACCATTGGCAATGAGCGGTTC-3′;
[0037] The β-actin reverse primer sequence is: 5'-AGGTCTTTGCGGATGTCCACGT-3'.
[0038] The NANOG forward primer sequence was: 5′-GAACTCTCCAACATCCTGAACCTC-3′;
[0039] The sequence of the NANOG reverse primer is: 5'-CCTTCTGCGTCACACCATTGC-3'.
[0040] The sequence of the OCT4 forward primer was: 5′-GAACTCTCCAACATCCTGAACCTC-3′;
[0041] The sequence of the OCT4 reverse primer is: 5'-CCTTCTGCGTCACACCATTGC-3'.
[0042] The sequence of the SOX2 forward primer was: 5′-AGGGAGATCGTGCAGACAA-3′;
[0043] The sequence of the SOX2 reverse primer was: 5′-AGCTGGAGCTGTCCTGGTAG-3′.
[0044] The sequence of the REX1 forward primer was: 5′-GGAATGTGGGAAAGCGCACGT-3′;
[0045] The sequence of the REX1 reverse primer is: 5'-CCGTGTGGATGCGCACGT-3'.
[0046] The IL-1β forward primer sequence was: 5′-CCACAGACCTTCCAGGAGAATG-3′;
[0047] The sequence of the IL-1β reverse primer was: 5′-GTGCAGTTCAGTGATCGTACAGG-3′.
[0048] The IL-6 forward primer sequence was: 5′-AGACAGCCACTCACCTCTTCAG-3′;
[0049] The IL-6 reverse primer sequence is: 5'-TTCTGCCAGTGCCTCTTTGCTG-3'.
[0050] The sequence of the TNF-α forward primer was: 5′-AAGGACACCATGAGCACTGAAAGC-3′;
[0051] The sequence of the TNF-α reverse primer was: 5′-AGGAAGGAGAAGAGGCTGAGGAAC-3′.
[0052] The experimental results showed that after 24 hours of stimulation of MSCs by INF-γ, TNF-α and IL-1β, the stemness effect was better maintained when the concentration of IFN-γ was 20 ng / mL and the concentration of TNF-α was 40 ng / mL ( Figure 1 AB), after IL-1β stimulated MSCs, the maintenance effect of stemness index was not significant ( Figure 1 C). After 24h of stimulation of MSCs by INF-γ, TNF-α and IL-1β, the expression of inflammatory factors in MSCs was significantly increased when the concentration of IFN-γ was 20ng / mL, the concentration of TNF-α was 40ng / mL and the concentration of IL-1β was 10ng / mL ( Figure 2 ).
[0053] Example 2 RT-qPCR detection of the expression of pro-inflammatory factors IL-1β, IL-6 and TNF-α mRNA
[0054] In order to explore the effect of pre-treated MSCs on the expression of macrophage inflammatory factors, the present invention detected the expression of THP1 macrophage inflammatory factors after co-culture of MSCs pre-treated with different concentrations of IL-1β, IFN-γ and TNF-α and THP1 macrophages infected with H37Ra.
[0055] The experimental process is as follows: THP1 cells were plated in a six-well plate, infected with H37Ra for 6 hours, and then co-cultured with MSCs for 24 hours, and total RNA in macrophage THP1 was extracted and reverse transcribed. The detailed steps are shown in Example 1. The primers used for fluorescence quantitative PCR are shown in Example 1.
[0056] The experimental results showed that after MSCs were pretreated with IL-1β and IFN-γ and co-cultured with THP1 macrophages infected with H37Ra, the expression of proinflammatory factors IL-1β, IL-6 and TNF-α in THP1 macrophages was significantly increased, and when the concentration of IL-1β was 10 ng / mL and the concentration of IFN-γ was 20 ng / mL, the expression level of inflammatory factors in THP1 macrophages was significantly increased; after MSCs were pretreated with TNF-α, although the expression levels of proinflammatory factors IL-1β, IL-6 and TNF-α in THP1 macrophages were reduced, the expression of inflammatory factors was still significantly increased compared with the blank control group ( Figure 3 ).
[0057] Example 3 Detection of reactive oxygen species using fluorescent probe DCFH-DA
[0058] In order to explore the effect of MSCs on the ROS release ability of macrophages, the present invention used untreated MSCs, MSCs pretreated with 10 ng / mL IL-1β, 20 ng / mL IFN-γ and 40 ng / mL TNF-α to co-culture with THP1 macrophages infected with H37Ra.
[0059] The experimental process is as follows: Using the Bio-Tech Reactive Oxygen Detection Kit, THP1 cells were plated in a six-well plate, infected with H37Ra for 6 hours, and co-cultured with MSCs for 48 hours. Experimental group, control group (CONTROL), blank group, and positive control group were set up respectively. The fluorescent probe DCFH-DA was diluted according to the instructions to a concentration of 10μmol / L. The cell culture medium was removed and 1.5mL of diluted DCFH-DA was added. Incubate for 20 minutes. Wash the cells three times with serum-free cell culture medium, collect the cells, and detect them on the machine.
[0060] The experimental results showed that the co-culture of MSCs with THP1 macrophages infected with H37Ra significantly increased the release of ROS from macrophages. Compared with untreated MSCs, the co-culture of MSCs pretreated with 10 ng / mL IL-1β with THP1 macrophages infected with H37Ra increased the release of ROS from THP1 macrophages ( Figure 4 ).
[0061] Example 4 Detection of cell apoptosis by Annexin V-FITC / PI double staining
[0062] In order to explore the ability of MSCs to detect macrophage apoptosis, the present invention used untreated MSCs, 10 ng / mL IL-1β, 20 ng / mL IFN-γ, 40 ng / mL TNF-α and 10 ng / mL IL-1β+20 ng / mL IFN-γ pretreated MSCs and co-cultured them with THP1 macrophages infected with H37Ra.
[0063] The experimental process is as follows: THP1 cells were plated in a six-well plate, infected with H37Ra for 6 hours, and co-cultured with MSCs for 48 hours. The cells were collected by digestion with EDTA-free trypsin and centrifuged at 1000rpm for 5 minutes. The supernatant was discarded, the cells were resuspended in PBS, centrifuged and precipitated, the supernatant was discarded, and the process was repeated once. Binding Buffer was diluted with water at a ratio of 1:3 and the cells were resuspended. The cell suspension was placed in a flow tube, and 5μL Annexin V / FITC and 10μL PI solution were added. After mixing, incubate in the dark for 15 minutes. 400μL PBS was added for detection.
[0064] The experimental results showed that compared with THP1 macrophages infected with H37Ra, the apoptotic ability of macrophages increased from 17.59% to 25.30% after MSCs were co-cultured with THP1 macrophages infected with H37Ra; compared with untreated MSCs, the apoptotic ability of THP1 macrophages was 25.89%, 28.14%, 28.93% and 26.15% after MSCs pre-treated with 10ng / mL IL-1β, 20ng / mL IFN-γ, 40ng / mL TNF-α and 10ng / mL IL-1β+20ng / mL IFN-γ were co-cultured with THP1 macrophages infected with H37Ra, respectively. Figure 5 ).
[0065] Example 5 Detection of Macrophage Pyroptosis-related Indicators by Western Blot
[0066] In order to explore the effect of pretreated MSCs on pyroptosis-related indicators in THP1 macrophages infected with Mtb, the present invention detected the expression of NLRP3 / GSDMD / Caspase-1 protein levels in THP1 macrophages after co-culture of untreated MSCs, 10ng / mL IL-1β, 20ng / mL IFN-γ, 40ng / mL TNF-α and 10ng / mL IL-1β+20ng / mL IFN-γ pretreated MSCs with THP1 macrophages infected with H37Ra.
[0067] The experimental process is as follows: THP1 cells were plated in a six-well plate, infected with H37Ra for 6 hours, and co-cultured with MSCs for 48 hours. The original culture medium of the cells was aspirated and washed three times with PBS; 200 μL lysis buffer (1% broad-spectrum protease inhibitor and 1% PMSF were added to the cells) was added to the cells and lysed on ice for 30 minutes; cells were scraped with a cell scraper; 5× protein loading buffer was added; the samples were boiled in a metal bath for 10 minutes, and the cell protein samples were stored in a -20℃ refrigerator after the boiling was completed.
[0068] Immuno-protein blotting includes the following steps: A1: gel preparation; A2: protein loading and electrophoresis: constant voltage 80V, 30min, then changed to constant voltage 120V, 90min; A3: transfer membrane at constant current 300mA, 2.5h; A4: blocking with skim milk at 4℃ for 1h; A5: washing membrane with 1×TBST, 5min / time; A6: incubating with primary antibody in a 4℃ refrigerator overnight; A7: washing membrane with 1×TBST, 5min / time; A8: incubating with secondary antibody at 4℃ for 2h; A9: imaging.
[0069] The experimental results showed that after MSCs were co-cultured with THP1 macrophages infected with H37Ra, the expression of NLRP3 / GSDMD / Caspase-1 in macrophages was significantly increased; compared with untreated MSCs, MSCs pretreated with 10ng / mL IL-1β, 20ng / mL IFN-γ, 40ng / mL TNF-α and 10ng / mL IL-1β+20ng / mL IFN-γ significantly increased the expression of NLRP3 / GSDMD / Caspase-1 in THP1 macrophages ( Figure 6 ).
[0070] Example 6 Bioinformatics analysis of the ability of immune-empowered MSCs to regulate THP1 macrophages against Mtb
[0071] The database construction was commissioned to BGI. The BGI multi-omics system online analysis platform was used to analyze the differences in gene expression levels of different genomes of MSCs / NC, 10ng / mL IL-1β-MSCs / NC, 20ng / mL IFN-γ-MSCs / NC, and 20ng / mL IFN-γ-MSCs / MSCs, and a bar graph was drawn; the microbial information online platform was used to perform a volcano plot analysis on the differentially expressed genes between the sorted genomes, and "|log2FC|>2 and P<0.05" was used as the screening threshold to obtain a volcano plot of significantly differentially expressed genes; up-regulated or down-regulated genomes were selected from the differentially expressed genes, and the BGI online analysis platform was used to perform KEGG pathway enrichment analysis, and the TOP 20 pathways were selected to draw a bubble chart; the microbial information online platform was used to screen the significant genes with "|log2FC|>1.5 and P<0.05" in the differentially expressed genes for Gene Ontology (GO) functional analysis including biological process (BP), molecular function (MF) and cell composition (CC). (The differential gene selection criteria for genes downregulated by 20 ng / mL IFN-γ-MSCs / NC were "|log2FC|>1 and P<0.05"); in order to reveal the potential interactions between differentially expressed proteins, STRING (v.11.0) was used to construct protein-protein interactions (PPI); the TOP 50 upregulated and downregulated genes in each group were selected using the Microbiome Online Platform for clustering heat map analysis.
[0072] Experiments have confirmed that after MSCs were pretreated with 10ng / mL IL-1β and 20ng / mL IFN-γ, the MSCs were far superior to the control group in terms of stemness maintenance and immune response ability. Therefore, a concentration of 10ng / mL IL-1β and 20ng / mL IFN-γ was used to explore the molecular mechanism.
[0073] 1. Transcriptome analysis of IL-1β pretreatment of MSCs regulating the anti-Mtb ability of THP1 macrophages
[0074] (1) Comparison of macrophage transcriptomes between co-culture with MSCs and without MSCs pre-treated with IL-1β
[0075] ① Comparison of differentially expressed genes
[0076] RNA-seq was used to analyze the transcriptome of THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 10 ng / mL IL-1β and THP1 macrophages infected with H37Ra without MSCs co-culture. The results showed that compared with THP1 macrophages infected with H37Ra without MSCs co-culture, there were 642 effective differentially expressed genes (|FC|≥2, q≤0.05) in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 10 ng / mL IL-1β, of which 354 were up-regulated genes and 288 were down-regulated genes ( Figure 7 The top 10 up-regulated genes were PTGES, NFE2, CYP26B1, IGFBP5, CCN4, ADGRG3, SLA, IL23A, LBP and EGFL8; the top 10 down-regulated genes were HS3ST1, ARX, FOXM1, CD1E, GIMAP1-GIMAP5, CXCL10, HTRA3, GLDN, TNFSF10 and LGI2 (Table 1).
[0077] Table 1 Top 10 up-regulated and down-regulated genes in Mtb-phagocytic macrophages treated with MSCs pretreated with 10 ng / mL IL-1β and those not treated with MSCs
[0078]
[0079]
[0080] ②GO functional enrichment analysis and KEGG pathway analysis
[0081] GO functional enrichment analysis of differentially expressed genes in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 10 ng / mL IL-1β and THP1 macrophages infected with H37Ra co-cultured without MSCs showed that the up-regulated differentially expressed genes were mainly concentrated in the response to bacterial sources and chemotaxis of leukocytes from the perspective of biological process classification; from the perspective of molecular function, they were mainly enriched in the activity of signal receptor activating factors, etc.; from the perspective of cellular components, they were mainly concentrated in the cell membrane and endoplasmic reticulum cavity, etc.; from the perspective of biological process classification, the down-regulated differentially expressed genes were mainly concentrated in the IFN-γ signaling pathway and cellular immune defense response; from the perspective of molecular function, they were mainly enriched in lipid transport activity, etc.; from the perspective of cellular components, they were mainly concentrated in lysosomes, etc. ( Figure 8 ). KEGG analysis results suggest that up-regulated genes are concentrated in the NOD-like receptor signaling pathway, and a large number of genes are also found to be involved in multiple aspects of inflammatory immunity, including antigen processing and presentation, phagosome and lysosome formation; down-regulated genes are concentrated in PI3K-AKT, MAPK signaling pathways and cytokine-cytokine receptor interactions ( Fig. 9 ).
[0082] (2) Comparison of macrophage transcriptomes in co-culture with IL-1β-pretreated MSCs and co-culture with MSCs alone
[0083] RNA-seq was used to perform transcriptome analysis on THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 10 ng / mL IL-1β and THP1 macrophages infected with H37Ra co-cultured with MSCs alone. The results showed that there were no differential genes in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 10 ng / mL IL-1β compared with THP1 macrophages infected with Mtb co-cultured with MSCs alone.
[0084] 2. Transcriptome analysis of IFN-γ pretreatment of MSCs regulating the anti-Mtb ability of THP1 macrophages
[0085] (1) Comparison of macrophage transcriptomes between co-culture with IFN-γ-pretreated MSCs and co-culture without MSCs
[0086] ① Comparison of differentially expressed genes
[0087] RNA-seq was used to perform transcriptome analysis on THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 20 ng / mL IFN-γ and THP1 macrophages infected with H37Ra co-cultured without MSCs. The results showed that compared with THP1 macrophages infected with H37Ra co-cultured without MSCs, there were 712 effective differentially expressed genes (|FC|≥2, q≤0.05) in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 20 ng / mL IFN-γ, including 272 up-regulated genes and 440 down-regulated genes ( Fig.10 The top 10 up-regulated genes were CXCL9, ANKRD22, SERPING1, LOC112268340, HLA-DRA, CYP26B1, PTGES, ADGRG3, GBP1 and NFE2; the top 10 down-regulated genes were FFAR3, RAD54L, RNF128, CTG2, ADORA3, SPARCL1, ADAMTS1, BDNF, STAC2 and GABRA4 (Table 2).
[0088] Table 2 Top 10 up-regulated and down-regulated genes in Mtb-phagocytic macrophages treated with MSCs pretreated with 20 ng / mL IFN-γ and Mtb-phagocytic macrophages not treated with MSCs
[0089]
[0090]
[0091] ②GO functional enrichment analysis and KEGG pathway analysis
[0092] GO functional enrichment analysis of differentially expressed genes in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 20 ng / mL IFN-γ and THP1 macrophages infected with H37Ra co-cultured without MSCs showed that the up-regulated differentially expressed genes were mainly concentrated in the response to IFN-γ from the perspective of biological process classification; from the perspective of molecular function, they were mainly enriched in MHC class II receptor activity, etc.; from the perspective of cellular components, they were mainly concentrated in MHC class II protein complexes and endoplasmic reticulum to Golgi transport vesicle membranes, etc.; from the perspective of biological process classification, the down-regulated differentially expressed genes were mainly concentrated in the regulatory pathways of homotypic cell adhesion; from the perspective of molecular function, they were mainly enriched in TGF-β signaling pathways and cytokine binding pathways, etc.; from the perspective of cellular components, they were mainly concentrated in the extracellular matrix containing collagen, etc. ( Fig.11). KEGG analysis suggests that in addition to the common cytokine receptor pathway, a large number of up-regulated genes are also involved in endoplasmic reticulum protein synthesis and C-type lectin receptor protein pathways; down-regulated genes are related to lysosome and phagosome formation ( Fig.12 ).
[0093] (2) Comparison of macrophage transcriptomes between co-cultured macrophages with IFN-γ pre-treated MSCs and co-cultured macrophages with MSCs alone
[0094] ① Comparison of differentially expressed genes
[0095] Transcriptome analysis was performed using RNA-seq on THP1 macrophages infected with H37Ra co-cultured with MSCs pre-treated with 20 ng / mL IFN-γ and THP1 macrophages infected with H37Ra co-cultured with MSCs alone. The results showed that compared with THP1 macrophages infected with H37Ra co-cultured with MSCs, there were 195 effective differentially expressed genes (|FC|≥2, q≤0.05) in THP1 macrophages infected with H37Ra co-cultured with MSCs pre-treated with 20 ng / mL IFN-γ, including 18 up-regulated genes and 177 down-regulated genes ( Fig.13 ). The top 10 up-regulated genes were CXCL9, ANKRD22, SERPING1, GBP1, HLA-DRA, ETV7, GBP4, FBXO39, CCL8, and CXCL10. The top 10 down-regulated genes were IGFBP5, COL10A1, FN1, AKAP12, TDRD6, OLR1, PDPN, SHROOM3, TNFRSF10, and PKDCC (Table 3).
[0096] Table 3 Top 10 up-regulated and down-regulated genes in macrophages phagocytosing Mtb treated with MSCs pretreated with 20 ng / mL IFN-γ and macrophages phagocytosing Mtb treated with MSCs
[0097]
[0098] ②GO functional enrichment analysis and KEGG analysis
[0099] GO functional enrichment analysis was performed on the differentially expressed genes in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with 20 ng / mL IFN-γ and THP1 macrophages infected with H37Ra co-cultured with MSCs alone. The results showed that the up-regulated differentially expressed genes were mainly concentrated in IFN-γ-related responses from the perspective of biological process classification, and were mainly enriched in immune receptor activity from the perspective of molecular function. From the perspective of cellular components, they were mainly concentrated in MHC class II protein complexes. From the perspective of biological process classification, the down-regulated differentially expressed genes were mainly concentrated in fatty acid metabolism. From the perspective of molecular function, they were mainly enriched in lipoprotein particle binding and low-density lipoprotein particle binding. From the perspective of cellular components, they were mainly in the extracellular matrix containing collagen, etc. ( Fig.14 ). KEGG analysis of up-regulated differentially expressed genes showed that the up-regulated genes were concentrated in pathways such as NOD-like receptors, C-type lectin receptor pathways, antigen processing and presentation. KEGG analysis of down-regulated differentially expressed genes showed that the down-regulated genes were related to cell cycle, etc. ( Fig.15 ).
[0100] (3) Comparison of macrophage transcriptomes under IFN-γ pre-treated MSCs co-culture, MSCs co-culture alone, and no co-culture conditions
[0101] VEN analysis was performed on the genes upregulated by 20ng / mL IFN-γ-MSCs / MSCs, MSCs / NC and 20ng / mL IFN-γ-MSCs / NC, and a total of 162 commonly upregulated genes were obtained. VEN analysis was performed on the downregulated genes, and a total of 109 commonly downregulated genes were obtained. Protein interaction network analysis was performed on the upregulated genes. The PPI network consisted of 162 gene / protein endpoints and 323 non-redundant interactions. The key genes that can be obtained are STAT3, PECAM1, ICAM1, CTNNB1, IRF8, CD274, PRDM1 and CEBPA, etc. Protein interaction network analysis was performed on the downregulated genes. The PPI network consisted of 108 gene / protein endpoints and 409 non-redundant interactions. The key genes that can be obtained are PA2G4, RPL12, BOP1, PDCD11, RPSA, NHP2, RPLP0, DKC1 and FN1, etc. ( Fig.16 ). KEGG pathway enrichment analysis was performed on the key genes displayed by the PPI network. It was found that the up-regulated genes were mainly distributed in Infectious disease: viral, Cancer: overview and Cell growth and death, etc. The specific genes are shown in Table 4, and the down-regulated genes were mainly distributed in Translation, Infectious disease: viral and Signal transduction, etc. The specific genes are shown in Table 5.
[0102] Table 4 KEGG analysis of up-regulated genes in 20ng / mL-IFN-γ-MSCs / MSCs, MSCs / NC and 20ng / mL-IFN-γ-MSCs / NC
[0103]
[0104]
[0105] Table 5 KEGG analysis of down-regulated genes in 20ng / mL-IFN-γ-MSCs / MSCs, MSCs / NC and 20ng / mL-IFN-γ-MSCs / NC
[0106]
[0107] Example 7 Detection of differential gene expression by RT-qPCR
[0108] The present invention co-cultured H37Ra-infected THP1 cells with immune-enhanced MSCs for 24 hours, and preliminarily screened the key immune molecules of immune-enhanced MSCs regulating THP1 macrophages by RNA level detection. The total RNA after THP1-Mtb co-cultured with MSCs was extracted by Trizol method, and the expression of differential genes was detected by RT-qPCR, wherein the detection primer sequence was:
[0109] The sequence of the PTGES forward primer was: 5′-GAGGATGCCCTGAGACACGGA-3′;
[0110] The sequence of the PTGES reverse primer is: 5'-CCAGAAAGGAGTAGACGAAGCC-3'.
[0111] The forward primer sequence for CYP26B1 was: 5′-GCACCTCTTTGAGGTCTACCAG-3′;
[0112] The sequence of the CYP26B1 reverse primer is: 5'-AGGATCTGCCGAGCCTGAATGC-3'.
[0113] The sequence of the ADGRG3 forward primer was: 5′-CCTCTACACCATCCGTGATAGG-3′;
[0114] The sequence of the ADGRG3 reverse primer is: 5'-AGGTGATGAGGAAGTAGCCGTG-3'.
[0115] The sequence of the SLA forward primer was: 5′-CCTGTCACCTTGCGTCAGAAGA-3′;
[0116] The sequence of the SLA reverse primer is: 5'-GCTGAAAAGGGACTCGTCTACC-3'.
[0117] The forward primer sequence for IGFBP5 was: 5′-CGTGCTGTGTACCTGCCCAATT-3′;
[0118] The sequence of the IGFBP5 reverse primer is: 5'-ACTTGTCCACGCACCAGCAGAT-3'.
[0119] The sequence of the LBP forward primer was: 5′-TCAGCATCTCCGACTCCTCCAT-3′;
[0120] The sequence of the LBP reverse primer is: 5'-CAGGAGGTTGACCGAAATGCTG-3'.
[0121] The IL-23A forward primer sequence was: 5′-GAGCCTTCTCTGCTCCCTGATA-3′;
[0122] The sequence of the IL-23A reverse primer is: 5'-GACTGAGGCTTGGAATCTGCTG-3'.
[0123] The sequence of the LRRC38 forward primer was: 5′-GGCTGTGCGACTGTGACTT-3′;
[0124] The sequence of the LRRC38 reverse primer is: 5'-GCTGAACCTACACTCGCTGAA-3'.
[0125] The CXCL9 forward primer sequence was: 5′-CTGTTCCTGCATCAGCACCAAC-3′;
[0126] The sequence of the CXCL9 reverse primer is: 5'-TGAACTCCATTCTTCAGTGTAGCA-3'.
[0127] The forward primer sequence for ANKRD22 was: 5′-GACAAAGCAGAATGAGGCTCTTG-3′;
[0128] The sequence of the ANKRD22 reverse primer is: 5'-AGCAGAGGGATAAGAGACTGGTT-3'.
[0129] The sequence of the SERPING1 forward primer was: 5′-GCATCAAAGTGACGACCAGCCA-3′;
[0130] The sequence of the SERPING1 reverse primer is: 5′-GTCTCTGTCAGTTCCAGCACTG-3′.
[0131] The sequence of the HLA-DRA forward primer was: 5′-AGCTGTGGACAAAGCCAACCTG-3′;
[0132] The sequence of the HLA-DRA reverse primer is: 5'-CTCTCAGTTCCACAGGGCTGTT-3'.
[0133] The sequence of the GBP1 forward primer was: 5′-TAGCAGACTTCTGTTCCTACATCT-3′;
[0134] The sequence of the GBP1 reverse primer is: 5'-CCACTGCTGATGGCATTGACGT-3'.
[0135] The sequence of the ETV7 forward primer was: 5′-CATCCTCACCAAGGACGACTTC-3′;
[0136] The sequence of the ETV7 reverse primer is: 5'-TCTTCAGCCTGAAGATCCCTCC-3'.
[0137] The sequence of the GBP4 forward primer was: 5′-CAGTCTTCATGGAGCACTCCTTC-3′;
[0138] The sequence of the GBP4 reverse primer is: 5'-TCAGGTGCTCTGAAAGCCGCTT-3'.
[0139] The forward primer sequence for FBXO39 was: 5′-CCTGAAGAGTCAGAAAGAACGGC-3′;
[0140] The sequence of the FBXO39 reverse primer is: 5'-CGATCAGCTTTCTGTACTTCCTG-3'.
[0141] The sequence of the forward primer for CCL8 was: 5′-TATCCAGAGGCTGGAGAGCTAC-3′;
[0142] The sequence of the CCL8 reverse primer is: 5'-TGGAATCCCTGACCCATCTCTC-3'.
[0143] The forward primer sequence for CXCL10 was: 5′-GGTGAGAAGAGATGTCTGAATCC-3′;
[0144] The sequence of the CXCL10 reverse primer was: 5′-GTCCATCCTTGGAAGCACTGCA-3′.
[0145] The experimental results showed that compared with THP1 macrophages infected with H37Ra, CYP26B1 increased significantly in THP1 macrophages infected with H37Ra co-cultured with MSCs; CYP26B1 increased significantly in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with IL-1β; CXCL9 increased significantly in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with IFN-γ. Compared with THP1 macrophages infected with H37Ra co-cultured with MSCs, CYP26B1 increased significantly in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with IL-1β; CXCL9 increased significantly in THP1 macrophages infected with H37Ra co-cultured with MSCs pretreated with IFN-γ ( Fig.17 ).
Claims
1. Use of empowered mesenchymal stem cells in the relief and / or adjuvant treatment and / or therapeutic drugs for tuberculosis.
2. The use according to claim 1, characterized in that: The empowered mesenchymal stem cells are mesenchymal stem cells activated by induction of inflammatory cytokines.
3. The use according to claim 2, characterized in that: The inflammatory cytokine is at least one of IFN-γ, TNF-α and IL-1β.
4. The use according to claim 1, 2 or 3, characterized in that: The drug is used for regulating the anti-tuberculosis ability of macrophages.
